Back
BlackRock Vs. Neurogene Industry Stock Comparison
Sell
50
BLK
BlackRock
Last Price:
$1,049.70
Seasonality Move:
3.88%
Sell
10
NGNE
Neurogene
Last Price:
$22.47
Seasonality Move:
18.83%
Sell
50
BlackRock (BLK)
is a Sell
Is BlackRock a Buy, Sell or Hold?
-
BLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NGNE Stock Price Chart
BLK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.31 | Buy |
Relative Strength Index (14 RSI): | 52.34 | Buy |
Chaikin Money Flow: | 397721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1023.48 - 1052.7) | Buy |
Bollinger Bands (100): | (889.98 - 1031.56) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.45 | Sell |
Relative Strength Index (14 RSI): | 39.99 | Sell |
Chaikin Money Flow: | 17850 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.49 - 25.09) | Buy |
Bollinger Bands (100): | (25.92 - 49.92) | Sell |
BLK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1041.78 | Sell |
20-day SMA: | 1039.25 | Buy |
50-day SMA: | 1023.31 | Buy |
200-day SMA: | 878.88 | Buy |
8-day EMA: | 1037.56 | Buy |
20-day EMA: | 1037.68 | Buy |
50-day EMA: | 1015 | Buy |
200-day EMA: | 905.03 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.96 | Sell |
20-day SMA: | 23.45 | Sell |
50-day SMA: | 36.87 | Sell |
200-day SMA: | 37.81 | Sell |
8-day EMA: | 22.84 | Sell |
20-day EMA: | 25.05 | Sell |
50-day EMA: | 31.73 | Sell |
200-day EMA: | 34.89 | Sell |
BlackRock Earnings Growth & BLK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.14 per share, and an increase next year of $5.23 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.
BlackRock Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |